Pantoprazolo Eg (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazolo Eg, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazolo Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Erosive esophagitis: heals mucosal damage caused by chronic acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent bowel habit changes.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider patient‑specific factors and monitor for potential complications. - Renal impairment: adjust dose if severe kidney disease is present. - Hepatic impairment: use with caution in moderate to severe liver disease. - Long‑term use: assess need periodically to avoid bone density loss. - Concomitant medications: review for possible drug‑drug interactions. - Pregnancy and lactation: evaluate risk‑benefit ratio with prescriber. - Store below 25°C: keep in original container, protect from moisture and direct sunlight.

Pantoprazole may affect the absorption or metabolism of several co‑administered drugs.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced antiviral efficacy. - Certain antifungals (e.g., itraconazole, ketoconazole): markedly decreased absorption. - Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR values. - Methotrexate: increased serum concentrations, especially in renal impairment. - Digoxin: modest increase in plasma levels. - Oral diabetes medications (e.g., gliclazide): may require dose adjustment.